A placebo controlled study of Aminogiuanidine in patients with diabetic Nephropathy to see whether the agent is effective in slowing the progression of renal disease in diabetics. Secondary endpoints will include the study of the effect of Aminogunidine on diabetic retinopathy.
Showing the most recent 10 out of 1103 publications